Your Bridge to China Biotech

For anyone listening closely to Illumina’s earnings calls, one question keeps resurfacing, explicitly or implicitly: Can China ever return

For Western life science investors, China’s healthcare and biotechnology ecosystem is often described in shorthand: fast, high-volume, state-backed, opaque.

China's Health System and the Role of AI China’s hospitals are in the midst of one of